NCT01237327 - Multicenter Follow Up Study Of Subjects Who Participated In An Original Protocol Of Exemestane Vs. Megestrol Acetate In Postmenopausal Women With Metastatic Breast Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 30, 2001

Primary Completion Date

December 31, 2007

Study Completion Date

December 31, 2009

Conditions

Metastatic Breast Cancer

Interventions

DRUG

Megestrol acetate

Megestrol Acetate 160 mg oral tablets Qd

DRUG

exemestane (Aromasin)

exemestane (Aromasin) 25 mg oral tablets Qd

Trial Locations (7)

Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Beijing

PLA 307 Hospital, Beijing

Cancer Hospital, Shanghai

Ba Yi Hospital, Cancer Center of CPLA, Nanjing

Jiangsu Cancer Hospital, Nanjing

The 2nd Central Hospital of Tianjin, Tianjin

The 1st Affiliated Hospital, Xi'an Jiao Tong University, Xi'an